Diagnostic procedures and management of dry eye

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Kaštelan, Snježana ^a   Tomić, Martina ^b   Salopek Rabatić, Jasminka ^a   Novak, Branko ^b  

^a University of Zagreb   (Croatia)

^b University of Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ARTIFICIAL TEAR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOSPORIN A; DIURETIC AGENT; FLUORESCEIN; ISOTRETINOIN; ROSE BENGAL;

ANTIINFLAMMATORY ACTIVITY; BLEPHAROSPASM; BURNING SENSATION; CANCER CHEMOTHERAPY; CLINICAL EXAMINATION; CONNECTIVE TISSUE DISEASE; CORNEA PERFORATION; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DRY EYE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPEROSMOLARITY; KERATITIS; KERATOCONJUNCTIVITIS SICCA; MEDICAL HISTORY; OCULAR SURFACE DISEASE; OCULAR SURFACE DISEASE INDEX; PHOTOPHOBIA; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; REFRACTIVE SURGERY; REVIEW; RISK FACTOR; SJOEGREN SYNDROME; STEVENS JOHNSON SYNDROME; TEAR FILM; TRACHOMA; CLASSIFICATION; DRY EYE SYNDROMES; LACRIMAL FLUID; METABOLISM; PATHOLOGY; SECRETION (PROCESS);

DRY EYE SYNDROMES; HUMANS; RISK FACTORS; TEARS;

EID: 84884245379     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/309723     Document Type: Review

References (40)

1. Behrens A., Doyle J. J., Stern L., Chuck R. S., McDonnell P. J., Azar D. T., Dua H. S., Hom M., Karpecki P. M., Laibson P. R., Lemp M. A., Meisler D. M., Castillo J. M. D., O'Brien T. P., Pflugfelder S. C., Rolando M., Schein O. D., Seitz B., Tseng S. C., Setten G. V., Wilson S. E., Yiu S. C., Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea 2006 25 8 900 907 2-s2.0-33750366586 10.1097/01.ico.0000214802.40313.fa
2. O'Brien P. D., Collum L. M. T., Dry eye: diagnosis and current treatment strategies. Current Allergy and Asthma Reports 2004 4 4 314 319 2-s2.0-5444267588
3. Nakamura H., Kawakami A., Eguchi K., Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjögren's syndrome. Translational Research 2006 148 6 281 288 2-s2.0-33845287655 10.1016/j.trsl.2006.07.003
4. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H. M., Alexander E. L., Carsons S. E., Daniels T. E., Fox P. C., Fox R. I., Kassan S. S., Pillemer S. R., Talal N., Weisman M. H., Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Annals of the Rheumatic Diseases 2002 61 6 554 558 2-s2.0-0036092482 10.1136/ard.61.6.554
5. Smith J. A., Albenz J., Begley C., Caffery B., Nichols K., Schaumberg D., Schein O., The epidemiology of dry eye disease: report of the epidemiology subcommittee of the international Dry Eye WorkShop (2007). Ocular Surface 2007 5 2 93 107 2-s2.0-34347257439
6. Miljanović B., Dana R., Sullivan D. A., Schaumberg D. A., Impact of dry eye syndrome on vision-related quality of life. American Journal of Ophthalmology 2007 143 3 409 e2 2-s2.0-33847082853 10.1016/j.ajo.2006.11.060
7. Schaumberg D. A., Sullivan D. A., Buring J. E., Dana M. R., Prevalence of dry eye syndrome among US women. American Journal of Ophthalmology 2003 136 2 318 326 2-s2.0-0042349408 10.1016/S0002-9394(03)00218-6
8. Schaumberg D. A., Sullivan D. A., Dana M. R., Epidemiology of dry eye syndrome. Advances in Experimental Medicine and Biology 2002 506 989 998 2-s2.0-0036921998
9. Moss S. E., Klein R., Klein B. E. K., Prevalance of and risk factors for dry eye syndrome. Archives of Ophthalmology 2000 118 9 1264 1268 2-s2.0-0033624389
10. Gayton J. L., Etiology, prevalence, and treatment of dry eye disease. Clinical Ophthalmology 2009 3 1 405 412 2-s2.0-75349093298
11. Clegg J., Guest J., Lehman A., Smith A., The annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom among patients managed by ophthalmologists. Ophthalmic Epidemiology 2006 13 4 263 274 2-s2.0-33746843606 10.1080/09286580600801044
12. Shimmura S., Shimazaki J., Tsubota K., Results of a population-based questionnaire on the symptoms and lifestyles associated with dry eye. Cornea 1999 18 4 408 411 2-s2.0-0032977517
13. Yazdani C., McLaughlin T., Smeeding J. E., Walt J., Prevalence of treated dry eye disease in a managed care population. Clinical Therapeutics 2001 23 10 1672 1682 2-s2.0-0035164737 10.1016/S0149-2918(01)80136-3
14. Jackson W. B., Management of dysfunctional tear syndrome: a Canadian consensus. Canadian Journal of Ophthalmology 2009 44 4 385 394 2-s2.0-68149148772 10.3129/i09-015
15. Pflugfelder S. C., Anti-inflammatory therapy of dry eye. Ocular Surface 2003 1 1 31 36 2-s2.0-4444280959
16. Latkany R., Dry eyes: etiology and management. Current Opinion in Ophthalmology 2008 19 4 287 291 2-s2.0-49849093565 10.1097/ICU.0b013e3283023d4c
17. Kastelan S., Lukenda A., Salopek-Rabatic J., Pavan J., Gotovac M., Dry eye symptoma and signs in long-term contact lens wearers. Collegium Antropologicum 2013 37 1 199 203
18. Salopek-Rabatic J., Pavan J., Kastelan S., Rabatic L., Glaucoma patients and contact lenses-how to fit-how to treat. Collegium Antropologicum 2013 37 1 195 199
19. Goto E., Yagi Y., Matsumoto Y., Tsubota K., Impaired functional visual acuity of dry eye patients. American Journal of Ophthalmology 2002 133 2 181 186 2-s2.0-0036143134 10.1016/S0002-9394(01)01365-4
20. Schiffman R. M., Christianson M. D., Jacobsen G., Hirsch J. D., Reis B. L., Reliability and validity of the ocular surface disease index. Archives of Ophthalmology 2000 118 5 615 621 2-s2.0-0343963066
21. Pinho Tavares F. D., Fernandes R. S., Bernardes T. F., Bonfioli A. A., Carneiro Soares E. J., Dry eye disease. Seminars in Ophthalmology 2010 25 3 84 93 2-s2.0-77954219840 10.3109/08820538.2010.488568
22. Buchholz P., Steeds C. S., Stern L. S., Wiederkehr D. P., Doyle J. J., Katz L. M., Figueiredo F. C., Utility assessment to measure the impact of dry eye disease. Ocular Surface 2006 4 3 155 161 2-s2.0-33748544250
23. Eperjesi F., Aujla M., Bartlett H., Reproducibility and repeatability of the OcuSense TearLab osmometer. Graefe's Archive for Clinical and Experimental Ophthalmology 2012 250 8 1201 1205 2-s2.0-84856983726 10.1007/s00417-012-1961-4
24. Karampatakis V., Karamitsos A., Skriapa A., Pastiadis G., Comparison between normal values of 2- and 5-minute schirmer test without anesthesia. Cornea 2010 29 5 497 501 2-s2.0-77951769010 10.1097/ICO.0b013e3181c2964c
25. Yokoi N., Bron A. J., Tiffany J. M., Maruyama K., Komuro A., Kinoshita S., Relationship between tear volume and tear meniscus curvature. Archives of Ophthalmology 2004 122 9 1265 1269 2-s2.0-4444264961 10.1001/archopht.122.9.1265
26. Bron A. J., Evans V. E., Smith J. A., Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 2003 22 7 640 650 2-s2.0-0141596908 10.1097/00003226-200310000-00008
27. Abelson M. B., Ousler G. W. III, Nally L. A., Welch D., Krenzer K., Alternative reference values for tear film break up time in normal and dry eye populations. Advances in Experimental Medicine and Biology 2002 506 1121 1125 2-s2.0-0036921915
28. Toker E., Asfurolu E., Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy. Cornea 2010 29 2 133 140 2-s2.0-77649120553 10.1097/ICO.0b013e3181acf68d
29. Ousler G. W. III, Hagberg K. W., Schindelar M., Welch D., Abelson M. B., The ocular protection index. Cornea 2008 27 5 509 513 2-s2.0-48249115209 10.1097/ICO.0b013e31816583f6
30. Fujihara T., Takeuchi T., Saito K., Kitajima Y., Kobayashi T. K., Tsubota K., Evaluation of human conjunctival epithelium by a combination of brush cytology and flow cytometry: an approach to the quantitative technique. Diagnostic Cytopathology 1997 17 6 456 460
31. Bron A. J., Abelson M. B., Ousler G., Pearce E., Tomlinson A., Yokoi N., Smith J. A., Begley C., Caffery B., Nichols K., Schaumberg D., Schein O., Calonge M., Baudouin C., Goto E., Grus F., Paugh J., Methodologies to diagnose and monitor dry eye disease: report of the diagnostic methodology subcommittee of the international Dry Eye Workshop (2007). Ocular Surface 2007 5 2 108 152 2-s2.0-34347256116
32. Stevenson W., Chauhan S. K., Dana R., Dry eye disease: an immune-mediated ocular surface disorder. Archives of Ophthalmology 2012 130 1 90 100 2-s2.0-84855586077 10.1001/archophthalmol.2011.364
33. Pflugfelder S. C., Geerling G., Kinoshita S., Lemp M. A., McCulley J., Nelson D., Novack G. N., Shimazaki J., Wilson C., Management and therapy of dry eye disease: report of the management and therapy subcommittee of the international Dry Eye WorkShop (2007). Ocular Surface 2007 5 2 163 178 2-s2.0-34347229411
34. Miljanović B., Trivedi K. A., Dana M. R., Gilbard J. P., Buring J. E., Schaumberg D. A., Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. American Journal of Clinical Nutrition 2005 82 4 887 893 2-s2.0-27744573477
35. Barabino S., Rolando M., Camicione P., Ravera G., Zanardi S., Giuffrida S., Calabria G., Systemic linoleic and γ -linolenic acid therapy in dry eye syndrome with an inflammatory component. Cornea 2003 22 2 97 101 2-s2.0-0037361797 10.1097/00003226-200303000-00002
36. Kojima T., Ishida R., Dogru M., Goto E., Matsumoto Y., Kaido M., Tsubota K., The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. American Journal of Ophthalmology 2005 139 2 242 246 2-s2.0-14244259489 10.1016/j.ajo.2004.08.040
37. Kinoshita S., Oshiden K., Awamura S., Suzuki H., Nakamichi N., A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye. Ophthalmology 2013 120 6 1158 1165
38. Baxter S. A., Laibson P. R., Punctal plugs in the management of dry eyes. Ocular Surface 2004 2 4 255 265 2-s2.0-20144386454
39. Tsubota K., Yamada M., Urayama K., Spectacle side panels and moist inserts for the treatment of dry-eye patients. Cornea 1994 13 3 197 201 2-s2.0-0028351815
40. Rosenthal P., Cotter J. M., Baum J., Treatment of persistent corneal epithelial defect with extended wear of a fluid-ventilated gas-permeable scleral contact lens. American Journal of Ophthalmology 2000 130 1 33 41 2-s2.0-0033825439 10.1016/S0002-9394(00)00379-2